Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide

Blood

Volumn 88, Issue 5, 1996, Pages 1805-1812

  Tu, Yiping ^a   Xu, Feng Hao ^a   Liu, Jin ^a   Vescio, Robert ^a   Berenson, James ^a   Fady, Catherine ^a   Lichtenstein, Alan ^a,b  

^a UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029794419     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1805.1805     Document Type: Article

References (32)

1. Dalton W, Grogan T, Rybski J, Scheper R, Richter R, Kailey J, Broxterman H, Pinedo H, Salmon SE: Immunohistochemical detection and quantitation of p-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation. Blood 73:747, 1989
2. Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistance in vitro in myeloma, lymphoma and breast cancer by p-glycoprotein staining. J Natl Cancer Inst 81:696, 1989
3. Epstein J, Xiao H, Oba BK: P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 74:913, 1989
4. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Dune B, Taylor C, Miller T, Salmon SE: Drug-resistance in multiple myeloma and lymphoma: Detection of p-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7:415, 1989
5. Gupta V, Singh SV, Ahmad H, Medh RD, Awasthi YC: Glutathione and glutathione-S-transferase in a human plasma cell line resistant to melphalan. Biochem Pharm 38:1993, 1989
6. Linsenmeyer ME, Jefferson S, Wolf M, Matthews JP, Board PG, Woodcock DM: Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma. Br J Cancer 65:471, 1992
7. Mariano M, Moretti L, Donelli A, Grantini M, Montagnani G, Di Prisco AU, Torelli G, Torelli U, Narni F: BCL-2 gene expression in hematopoietic cell differentiation. Blood 80:768, 1992
8. Peettersson M, Jernberg-Wiklund H, Larsson LG, Sundstom C, Givol I, Tsujimoto Y, Nilsson K: Expression of the BCL-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood 79:495, 1992
9. Durie BGM, Mason DY, Giles F, Vela E, Knioght E, Wolff I, Foadi M, Samson D: Expression of the BCL-2 oncogene protein in multiple myeloma. Blood 76:347a, 1990 (abstr, suppl 1)
10. Yunis JJ, Mayer MG, Arensen MA, Aeppli DP, Oken MM, Frizzera G: BCL-2 and other genomic alterations in the prognosis of large cell lymphomas. N Eng J Med 320:1047, 1990
11. Campos L, Roualult JiP, Sabido O, Oriol P, Roubi N, Vasselon C: High expression of BCL-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091, 1993
12. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh JT: Expression of the proto-oncogene BCL-2 in the prostate and its association with emergence of androgen independent prostate cancer. Cancer Res 52:6940, 1992
13. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G: Expression of the apoptosis-suppressing protein BCL-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543, 1994
14. Grogan TM, Spier CM, Salmon SE, Matzner M, Rybski J, Weinstein RS, Scheper RJ, Dalton WS: P-glycoprotein expression in human plasma cell myeloma: Correlation with prior chemotherapy. Blood 81:490, 1993
15. Petrini M, Di Simone D, Favati A, Mattii L, Valentini P, Grassi B: GST and p-170 co-expression in multiple myeloma. Br J Hematol 90:393, 1995
16. Krajewski S, Chatten J, Hanada M, Reed JC: Immunohistochemical analysis of the BCL-2 oncoprotein in human neuroblastomas. Lab Invest 72:42, 1995
17. Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J: Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248, 1995
18. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dolken G: Expression of BCL-2 in Burkitt's lymphoma cell lines: Induction by latent Epstein-Barr virus genes. Blood 80:459, 1992
19. Kwok TK, Mok CH, Menton-Brennan L: Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. Cancer Res 54:2834, 1994
20. Fritsch M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307, 1992
21. Cherfas J: Cells found dead; p53 held for questioning. Science watch 5:8, 1994
22. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
23. Selvakumaran M, Lin H-K, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D: Immediate early upregulation of bax expression by p53 but not TGF betal: A paradigm for distinct apoptotic pathways. Oncogene 9:1791, 1994
24. Haldar S, Negrini M, Monne M, Sabbioni S, Croce C: Downregulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095, 1994
25. Mazars G-R, Portier M, Zhang X-G, Jourdan M, Bataille R, Theillet C, Klein B: Mutations of the p53 gene in human myeloma cell lines. Oncogene 7:1015, 1992
26. Neri A, Baldini L, Trecca D, Cro L, Polli E, Maiolo T: p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81:128, 1993
27. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131, 1994
28. Sinha BK, Mimnaugh EG, Rajagopalan S, Myers CE: Adriamycin activation and oxygen free radical formation in human breast tumor cells: Protective role of glutathione peroxidase in adriamycin resistance. Cancer Res 49:3844, 1989
29. Haim N, Roman J, Nemec J, Sinha BK: Peroxidative free radical formation and O-demethylation of etoposide and teniposide. Biochem Biophys Res Commun 135:215, 1986
30. Schreck R, Albermann K, Baeuerle PA: Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Rad Res Commun 17:221, 1992
31. Abate C, Patel L, Rauscher FJ, Curran T: Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157, 1990
32. Hu ZB, Yang GS, Miyamoto N, Minden MD, McCulloch EA: Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: Involvement of free radicals. Leukemia 9:789, 1995